InvestorsHub Logo
Followers 40
Posts 1456
Boards Moderated 0
Alias Born 09/23/2013

Re: None

Monday, 09/30/2013 9:41:19 AM

Monday, September 30, 2013 9:41:19 AM

Post# of 144814
$NVLX After presenting the results of its large scale Phase III clinical trial at the 2013 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology in late January, the U.S. Food and Drug Administration (FDA) moved quickly to approve Celgene Corp.'s ABRAXANE® when used in combination with gemcitabine.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News